{
    "nct_id": "NCT03359811",
    "official_title": "Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway: A Non-inferiority Randomized Controlled Trial",
    "inclusion_criteria": "1. Written Informed consent\n2. 18 years old or older\n3. American Society of Anesthesiologists physical status (ASA) 1-3\n4. Scheduled surgery: open elective CRS-HIPEC\n5. Able to complete the QoR 15 questionnaire\n6. Patients scheduled to receive intraoperative chemotherapy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Thrombocytopenia (platelet count: <100,000 cell/dL), coagulopathy (International Normalized Ratio > 1.5, PT>16.5 seconds or aPTT > 35.9 seconds)\n2. Bupivacaine or liposomal bupivacaine sensitive or known allergy;\n3. Pregnancy or breastfeeding patients\n4. Patients with recent (within 60 days preoperatively) history severe hepatic disease (defined as liver injury with encephalopathy plus impaired synthetic liver function (i.e. >1.5)\n5. Patients with recent (within 15 days preoperatively) history deteriorate kidney function (creatinine serum concentrations > 2.5 mg/dL or eGFR < 30 mL/kg/min)\n6. Chronic opioid use defined as daily opioid use for more than one month prior the scheduled date of surgery",
    "miscellaneous_criteria": ""
}